StageZero Life Sciences Ltd. (SZLSF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 3.79 Million | 5.06 Million | 4.15 Million | 138.7 Thousand | 185.87 Thousand | 411.66 Thousand |
| Cost of Revenue | 4.19 Million | 3.89 Million | 3.45 Million | 1.09 Million | 1.26 Million | 1.4 Million |
| Gross Profit | -403.74 Thousand | 1.17 Million | 695.55 Thousand | -960.91 Thousand | -1.07 Million | -992.7 Thousand |
| Operating Expenses | 7.34 Million | 9.3 Million | 4.05 Million | 4.17 Million | 3.28 Million | 4.16 Million |
| Selling, General and Administrative Expenses | 6.65 Million | 8.22 Million | 4.02 Million | 4.17 Million | 3.28 Million | 4.16 Million |
| Research and Development Expenses | 351.99 Thousand | 774.53 Thousand | 218.69 Thousand | - | - | - |
| Other Expenses | 338.88 Thousand | 311.34 Thousand | 29.66 Thousand | 27.28 Thousand | 12.33 Thousand | 1.46 Million |
| Cost and Expenses | 11.54 Million | 13.19 Million | 7.5 Million | 5.27 Million | 4.55 Million | 5.56 Million |
| Operating Income | -7.74 Million | -8.13 Million | -3.69 Million | -5.11 Million | -4.35 Million | -3.89 Million |
| Interest Expense | 284.06 Thousand | 200.3 Thousand | 320.42 Thousand | 803.19 Thousand | 1.12 Million | 225.69 Thousand |
| Income Tax Expense | - | 200.3 Thousand | 320.42 Thousand | 830.48 Thousand | 1.14 Million | 1.68 Million |
| Earnings before Tax | -11.41 Million | -7.48 Million | -6.86 Million | -3.48 Million | -3.94 Million | -2.94 Million |
| Net Income | -11.41 Million | -7.68 Million | -7.18 Million | -4.31 Million | -3.94 Million | -2.94 Million |
| Earnings Per Share Basic | -0.11 | -0.11 | -0.16 | -0.16 | -0.23 | -0.24 |
| Earnings Per Share Diluted | -0.11 | -0.11 | -0.16 | -0.16 | -0.23 | -0.24 |
| Weighted Average Shares Outstanding | 99.42 Million | 70.71 Million | 44.82 Million | 26.49 Million | 17.1 Million | 12.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 99.42 Million | 70.71 Million | 44.82 Million | 26.49 Million | 17.1 Million | 12.08 Million |
| Gross Margin | -0.11 | 0.23 | 0.17 | -6.93 | -5.81 | -2.41 |
| EBIT Margin | -2.71 | -1.50 | -0.84 | -34.71 | -21.76 | -8.62 |
| Profit Margin | -3.01 | -1.52 | -1.73 | -31.09 | -21.22 | -7.16 |
| EBITDA | -10.27 Million | -7.62 Million | -6.25 Million | -2.43 Million | -2.66 Million | -2.25 Million |
| Earnings Before Tax Margin | -2.04 | -1.60 | -0.89 | -36.86 | -23.43 | -9.47 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 390.08 Thousand | 519.58 Thousand | 745.48 Thousand | 793.3 Thousand | 778.51 Thousand | 3.79 Million |
| Cost of Revenue | 382.26 Thousand | 238.58 Thousand | 577.07 Thousand | 671.75 Thousand | 642.42 Thousand | 4.19 Million |
| Gross Profit | 7818.00 | 281 Thousand | 168.41 Thousand | 121.55 Thousand | 136.08 Thousand | -403.74 Thousand |
| Operating Expenses | 703.1 Thousand | 595.77 Thousand | 929.14 Thousand | 942.3 Thousand | 1.42 Million | 7.43 Million |
| Selling, General and Administrative Expenses | 703.1 Thousand | 595.77 Thousand | 909.41 Thousand | 859.07 Thousand | 1.28 Million | - |
| Research and Development Expenses | - | - | 19.72 Thousand | 83.23 Thousand | 61.01 Thousand | - |
| Other Expenses | - | 47.23 Thousand | - | -5405.00 | 80.67 Thousand | 426.31 Thousand |
| Cost and Expenses | 1.08 Million | 834.36 Thousand | 1.5 Million | 1.61 Million | 2.06 Million | 11.62 Million |
| Operating Income | -695.28 Thousand | -314.77 Thousand | -760.73 Thousand | -820.75 Thousand | -1.28 Million | -7.74 Million |
| Interest Expense | 52.66 Thousand | 40.75 Thousand | 26.85 Thousand | 99.88 Thousand | 45.83 Thousand | 219.2 Thousand |
| Income Tax Expense | 98.49 Thousand | 2.00 | 26.85 Thousand | 99.88 Thousand | 384.54 Thousand | 3.29 Million |
| Earnings before Tax | -649.46 Thousand | -384.62 Thousand | -821.88 Thousand | -401.53 Thousand | -1.81 Million | -11.41 Million |
| Net Income | -649.46 Thousand | -384.62 Thousand | -821.88 Thousand | -401.53 Thousand | -2.19 Million | -14.71 Million |
| Earnings Per Share Basic | -0.01 | -0.00 | -0.01 | -0.00 | -0.02 | - |
| Earnings Per Share Diluted | -0.01 | -0.00 | -0.01 | -0.00 | -0.02 | - |
| Weighted Average Shares Outstanding | 123.55 Million | 123.55 Million | 123.53 Million | 122.71 Million | 105.53 Million | 99.42 Million |
| Weighted Average Shares Outstanding (Diluted) | 123.55 Million | 123.55 Million | 123.53 Million | 122.71 Million | 105.53 Million | 99.42 Million |
| Gross Margin | 0.02 | 0.54 | 0.23 | 0.15 | 0.17 | -0.11 |
| EBIT Margin | -1.42 | -0.57 | -0.97 | -0.96 | -1.70 | - |
| Profit Margin | -1.66 | -0.74 | -1.10 | -0.51 | -2.82 | -3.88 |
| EBITDA | -552.98 Thousand | -296.57 Thousand | -722.63 Thousand | -761.17 Thousand | -1.32 Million | - |
| Earnings Before Tax Margin | -1.78 | -0.61 | -1.02 | -1.03 | -1.65 | -2.04 |
DANE
PSKOF
MNKS
TGIFF
CYAN
2719